Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Combined Treatment with a WNT Inhibitor and the NSAID Sulindac Reduces Colon Adenoma Burden in Mice with Truncated APC.

Autor: Faux MC; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.; Department of Surgery, RMH, University of Melbourne, Parkville, Victoria, Australia., Weinstock J; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.; Deceased., Gogos S; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia., Prato E; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia., Azimpour AI; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia., O'Keefe R; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia., Cathcart-King Y; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia., Garnham AL; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia., Ernst M; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia., Preaudet A; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia., Christie M; Department of Pathology, Royal Melbourne Hospital, Parkville, Victoria, Australia., Putoczki TL; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.; Department of Surgery, RMH, University of Melbourne, Parkville, Victoria, Australia., Buchert M; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia., Burgess AW; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.; Department of Surgery, RMH, University of Melbourne, Parkville, Victoria, Australia.

Publikováno v: Cancer research communications [Cancer Res Commun] 2022 Feb 02; Vol. 2 (2), pp. 66-77. Date of Electronic Publication: 2022 Feb 02 (Print Publication: 2022).